Diagnostics Pipeline: 2024 Trends in FDA Approvals
In vitro diagnostic products approved by the U.S. Food and Drug Administration in 2024 show a continued move toward rapid and point-of-care tests
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
In vitro diagnostic products approved by the U.S. Food and Drug Administration in 2024 show a continued move toward rapid and point-of-care tests
Several years after the onset of the COVID-19 pandemic, labs are still dealing with the effects of missed and delayed screenings
Learn how research and development labs can leverage AI to transform laboratory data into actionable insights
A new NIH network aims to remove barriers and share knowledge to drive more widespread adoption of genomics in clinical settings
The EasyScreen assay received 510(k) clearance from the Food and Drug Administration earlier this year–but with a catch
How artificial intelligence and machine learning tools stand to benefit clinical labs throughout the genomics pathway
Understanding the regulatory landscape of genetic and genomic testing, and its impact on clinical practice
With patient and provider demand for WGS on the rise, what should laboratorians know about ordering and interpreting this testing?
AI can help alleviate the burden on clinical labs—but only with sufficient investment, enthusiasm, and understanding
How three companies are addressing screening challenges with tests that help improve chances of early detection
Computational biology expert Keaun Amani shares his advice and insights on AI and machine learning tools for the clinical lab